2016
DOI: 10.3390/cells5040043
|View full text |Cite
|
Sign up to set email alerts
|

Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer

Abstract: Glycosylation is one of the most important modifications of proteins and lipids, and cell surface glycoconjugates are thought to play important roles in a variety of biological functions including cell-cell and cell-substrate interactions, bacterial adhesion, cell immunogenicity and cell signaling. Alterations of glycosylation are observed in number of diseases such as cancer and chronic inflammation. In that context, pro-inflammatory cytokines have been shown to modulate cell surface glycosylation by regulati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
49
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(56 citation statements)
references
References 148 publications
(160 reference statements)
1
49
0
1
Order By: Relevance
“…There are two major findings of the present study: (i) Expression of the N-acetylglucosaminyltransferase GCNT2 and its product, I antigen, is strongly induced during EMT by EGF and bFGF treatment of colon cancer cells, and (ii) the miR-199 family plays a key role in this process. Cancer cells undergo drastic changes in the repertoire of their cell surface glycans during their tumorigenic progression, with concomitant changes in the cellular transcription program and post-transcriptional regulation [24][25][26][27][28][29][30][31]. Certain glycans that are frequently found in cancers can be utilized as diagnostic markers.…”
Section: Discussionmentioning
confidence: 99%
“…There are two major findings of the present study: (i) Expression of the N-acetylglucosaminyltransferase GCNT2 and its product, I antigen, is strongly induced during EMT by EGF and bFGF treatment of colon cancer cells, and (ii) the miR-199 family plays a key role in this process. Cancer cells undergo drastic changes in the repertoire of their cell surface glycans during their tumorigenic progression, with concomitant changes in the cellular transcription program and post-transcriptional regulation [24][25][26][27][28][29][30][31]. Certain glycans that are frequently found in cancers can be utilized as diagnostic markers.…”
Section: Discussionmentioning
confidence: 99%
“…Pro-inflammatory cytokines have been reported to regulate the expression of glycosyltransferases involved in the biosynthesis of disease-associated glycans. In particular, TNF was found able to up-regulate ST3GAL4 in human lung increasing sLe x expression [105]. It is worth recalling that sLe antigens can be carried by a glycosphingolipid backbone, forming gangliosides.…”
Section: Plasma Carriers Of Slex or Sleamentioning
confidence: 99%
“…[8][9][10] There is ample evidence that sialic acids are important bioinformatic molecules, which play pivotal roles in biological, pathological, and immunological processes through modifying glycoproteins and glycolipids on the cell surface, including nervous system embryogenesis, 11 cell-cell interactions, 12,13 signal transduction, 14 bacterial and viral infection, 15,16 etc In addition, sialic acids on cell membranes are closely related to tumor invasion and metastasis. [24][25][26] In fact, the increased sialylation and expressions of these sialyltransferases genes in cervical cancer were also reported. For example, ST6GAL1 regulates macrophage apoptosis by controlling the α2,6-sialylation of tumor necrosis factor receptor-1.…”
Section: Introductionmentioning
confidence: 99%